Abstract

Stimulator of interferon genes (STING) is a key cytosolic receptor for small nucleotides and plays a key role in anticancer and antiviral immunity. Cyclic dinucleotide STING agonists may comprise a novel class of vaccine adjuvants capable of inducing cellular immune responses and protective efficacy against intracellular pathogens. We generated a recombinant Bacillus Calmette-Guérin ([BCG] BCG-disA-OE) that overexpresses the endogenous mycobacterial diadenylate cyclase gene and releases high levels of the STING agonist bis-(3'-5')-cyclic dimeric adenosine monophosphate (c-di-AMP). We used a 24-week guinea pig vaccination-Mycobacterium tuberculosis (M.tb.) challenge model to test the protective efficacy of BCG-disA-OE versus wild-type BCG and measured lung weights, pathology scores, and M.tb. organ colony-forming unit (CFU) counts. BCG-disA-OE elicited significantly stronger tumor necrosis factor-α, interleukin (IL)-6, IL-1β, interferon (IFN) regulatory factor 3, and IFN-β levels than BCG-wild type (WT) in vitro in murine macrophages. In vivo in guinea pigs, we found that BCG-disA-OE reduced lung weights, pathology scores, and M.tb. CFU counts in lungs by 28% (P < .05), 34%, and 2.0 log10 CFU units (P < .05) compared with BCG-WT, respectively. We report a strategy of delivering a STING agonist from within live BCG. Overproduction of the STING agonist c-di-AMP significantly enhanced the protective efficacy of BCG against pulmonary and extrapulmonary tuberculosis. Our findings support the development of BCG-vectored STING agonists as a tuberculosis vaccine strategy.

Highlights

  • Recent studies have identified a key role for the stimulator of interferon genes (STING) intracellular sensor in mediating innate immune responses cellular stress or pathogen infection [1,2]

  • As they are capable of inducing potent cytokine and cellular immune responses against pathogens, cyclic dinucleotides (CDNs) Stimulator of interferon genes (STING) agonists exhibit attractive vaccine adjuvant properties

  • We showed that mutation of the cdnP gene encoding a cyclic dinucleotide phosphodiesterase (CdnP) that hydrolyzes c-di-AMP lead to a mutant Mycobacterium tuberculosis (Mtb) strain that accumulates c-di-AMP and is attenuated for virulence [13]

Read more

Summary

Introduction

Recent studies have identified a key role for the stimulator of interferon genes (STING) intracellular sensor in mediating innate immune responses cellular stress or pathogen infection [1,2]. STING agonists is currently being tested for enhancement of antitumor immunity and as potential anti-viral therapy [5,7]. As they are capable of inducing potent cytokine and cellular immune responses against pathogens, CDN STING agonists exhibit attractive vaccine adjuvant properties. They increase expression of MHC class II, co-stimulatory molecules (CD80/CD86) as well as activation (CD40) and adhesion (CD45) markers; in addition

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.